Lhousni, Saida and Belmokhtar, Karam Yahya and Belmokhtar, Ihab and Elidrissi Errahhali, Mounia and Elidrissi Errahhali, Manal and Boulouiz, Redouane and Tajir, Mariam and Charif, Majida and Zerrouki, Khawla and Benajiba, Noufissa and Rkain, Maria and Babakhouya, Abdeladim and Kouismi, Hatim and Thouil, Afaf and Latrach, Hanane and Amrani, Rim and Messaoudi, Sahar and Ayyad, Anass and Sidqi, Zaina and Andaloussi Serraj, Khalid and Hamaz, Siham and Alaoui, Habiba and Bachir, Houda and Bentata, Yassamine and Haddiya, Intissar and Choukri, Mohammed and Seddik, Rachid and Bennani, Amal and Dikhaye, Siham and Oneib, Bouchra and Elghazouani, Fatima and El Mahi, Omar and Benzirar, Adnane and Oufkir, Ayat Allah and Housni, Brahim and Mimouni, Ahmed and Saadi, Hanane and Belahcen, Mohammed and El Harroudi, Tijani and Ouarzane, Meryem and Bellaoui, Mohammed and Diaz, Daniel (2020) Morocco’s First Biobank: Establishment, Ethical Issues, Biomedical Research Opportunities, and Challenges. BioMed Research International, 2020. pp. 1-11. ISSN 2314-6133
![[thumbnail of 8812609.pdf]](http://studies.sendtopublish.com/style/images/fileicons/text.png)
8812609.pdf - Published Version
Download (1MB)
Abstract
Background. Biobanks are highly organized infrastructures that allow the storage of human biological specimens associated with donors’ personal and clinical data. These infrastructures play a key role in the development of translational medical research. In this context, we launched, in November 2015, the first biobank in Morocco (BRO Biobank) in order to promote biomedical research and provide opportunities to include Moroccan and North African ethnic groups in international biomedical studies. Here, we present the setup and the sample characteristics of BRO Biobank. Methods. Patients were recruited at several departments of two major health-care centers in the city of Oujda. Healthy donors were enrolled during blood donation campaigns all over Eastern Morocco. From each participant, personal, clinical, and biomedical data were collected, and several biospecimens were stored. Standard operating procedures have been established in accordance with international guidelines on human biobanks. Results. Between November 2015 and July 2020, 2446 participants were recruited into the BRO Biobank, of whom 2013 were healthy donors, and 433 were patients. For healthy donors, the median age was 35 years with a range between 18 and 65 years and the consanguinity rate was 28.96%. For patients, the median age was 11 years with a range between 1 day and 83 years. Among these patients, 55% had rare diseases (hemoglobinopathies, intellectual disabilities, disorders of sex differentiation, myopathies, etc.), 13% had lung cancer, 4% suffered from hematological neoplasms, 3% were from the kidney transplantation project, and 25% had unknown diagnoses. The BRO Biobank has collected 5092 biospecimens, including blood, white blood cells, plasma, serum, urine, frozen tissue, FFPE tissue, and nucleic acids. A sample quality control has been implemented and suggested that samples of the BRO Biobank are of high quality and therefore suitable for high-throughput nucleic acid analysis. Conclusions. The BRO Biobank is the largest sample collection in Morocco, and it is ready to provide samples to national and international research projects. Therefore, the BRO Biobank is a valuable resource for advancing translational medical research.
Item Type: | Article |
---|---|
Subjects: | e-Archives > Medical Science |
Depositing User: | Managing Editor |
Date Deposited: | 19 May 2023 06:29 |
Last Modified: | 12 Jul 2025 05:26 |
URI: | http://studies.sendtopublish.com/id/eprint/347 |